Euro Surveill. 2024 Aug;29(31). doi: 10.2807/1560-7917.ES.2024.29.31.2400459.
ABSTRACT
As other European countries, France is experiencing a resurgence of pertussis in 2024. Between 1 January and 31 May 2024, 5,616 (24.9%) positive Bordetella pertussis qPCR tests were identified, following a 3-year period of almost null incidence. Of 67 cultured and whole genome sequenced B. pertussis isolates, 66 produced pertactin and 56 produced FIM2, in contrast to pre-COVID-19 years. One isolate of genotype Bp-AgST4 was resistant to macrolides. Pertussis resurgence may favour isolates that produce FIM2 and pertactin.
PMID:39092529 | DOI:10.2807/1560-7917.ES.2024.29.31.2400459
